Insider Transactions in Q3 2023 at Intercept Pharmaceuticals, Inc. (ICPT)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2023
|
Andrew Saik EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
908
-1.31%
|
$9,080
$10.8 P/Share
|
|
Sep 14
2023
|
M Michelle Berrey President, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,246
-1.53%
|
$13,706
$11.57 P/Share
|
|
Aug 01
2023
|
Jared Freedberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
771
-1.33%
|
$7,710
$10.5 P/Share
|